A new study indicates that higher prostate cancer death rates among black men in the United States may be due to a higher risk of developing preclinical prostate cancer as well as a higher risk of that cancer progressing more quickly to advanced stages.
Read More
The kit will enable diagnostic laboratories with manual and automated RNA extraction and polymerase chain reaction platforms to perform the SelectMDx liquid biopsy test in their own facilities.
Read MoreThe prostate health index test from Beckman Coulter Diagnostics is a simple, multianalyte blood test that helps physicians distinguish prostate cancer from benign prostatic conditions in men aged 50 years or older.
Read MoreA number of oncology centers have developed and implemented liquid biopsy tests not only for lung cancer, but for breast, colorectal, gynecologic, ovarian, prostate, and skin cancers as well.
Read More
This month’s issue features immunoassay analyzers from such companies as Arlington Scientific and Dynex Technologies.
Read More